Omalizumab for the Treatment of Multiple Food Allergies.
Robert A WoodAlkis TogiasScott H SichererWayne G ShrefflerEdwin H KimStacie M JonesDonald Y M LeungBrian P VickeryJ Andrew BirdJonathan M SpergelAhmar IqbalJulie OlssonMonica Ligueros-SaylanAlkaz UddinAgustin CalatroniCharmaine Marquis HuckabeeNicole H RogersNancy YovetichJennifer DantzerKim MuddJulie WangMarion GroetchDavid PyleCorinne A KeetMichael KulisSayantani B SindherAndrew LongAmy M ScurlockBruce J LanserTricia LeeChristopher ParrishTerri Brown-WhitehornAmanda K Rudman SpergelMaria VeriSanaz Daneshfar HamrahErica BrittainJulian PoyserLisa M WheatleyR Sharon ChinthrajahPublished in: The New England journal of medicine (2024)
In persons as young as 1 year of age with multiple food allergies, omalizumab treatment for 16 weeks was superior to placebo in increasing the reaction threshold for peanut and other common food allergens. (Funded by the National Institute of Allergy and Infectious Diseases and others; ClinicalTrials.gov number, NCT03881696.).